Want to see IN:EPIGRAL full AI Analyst Report?
EPIGRAL Stock Chart & Stats
₹1163.05
-₹5.70(-0.49%)
At close: 4:00 PM EDT
₹1163.05
-₹5.70(-0.49%)
Day’s Range― - ―
52-Week Range₹806.20 - ₹1,714.85
Previous CloseN/A
Volume649.06K
Average Volume (3M)2.17K
Market Cap
₹38.98B
Enterprise Value₹40.59B
Total Cash (Recent Filing)₹50.20M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)14.4
Beta1.33
Next Earnings
Nov 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.55%
Share Statistics
EPS (TTM)62.82
Shares Outstanding43,141,340
10 Day Avg. Volume2,173
30 Day Avg. Volume2,173
Financial Highlights & Ratios
PEG Ratio-1.15
Price to Book (P/B)1.57
Price to Sales (P/S)1.40
P/FCF Ratio-535.43
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)66.9
Revenue Forecast (FY)₹27.83B
Bulls Say, Bears Say
Bulls Say
Low LeverageA materially lower debt burden strengthens financial resilience and reduces interest-related pressure on future earnings. The improved capital structure should give Epigral greater flexibility to sustain operations, manage industry cycles, and allocate capital toward growth.
Healthy ProfitabilityHealthy operating and net margins indicate that Epigral retains meaningful earnings power in its chemical operations. Attractive returns on equity also suggest the business can generate solid profitability from its capital base, supporting reinvestment and resilience.
Established Textile Chemical DemandThe company supplies multiple chemical inputs used across fabric preparation, dyeing, printing, and finishing. This embedded role in textile production creates recurring industrial demand and diversifies revenue across several necessary processing applications.
Bears Say
Weak Free Cash FlowNegative free cash flow weakens the quality of reported profits and can reduce internally generated funding for expansion, debt reduction, or shareholder returns. The sharp deterioration also indicates that cash generation may remain sensitive to working-capital or investment demands.
Margin CompressionFlat revenue combined with materially lower gross and operating margins signals reduced earnings momentum and weaker operating leverage. If this pattern persists, Epigral may have less capacity to absorb costs or preserve profitability when textile-sector demand or pricing becomes less favorable.
Earnings DeteriorationThe sharp decline in EPS indicates that earnings power has weakened despite the company remaining profitable. Continued pressure would reduce the capital base's productivity, constrain retained-profit growth, and make future performance more dependent on a recovery in margins.
Epigral Ltd News
EPIGRAL FAQ
What was Epigral Ltd’s price range in the past 12 months?
Epigral Ltd lowest stock price was ₹806.20 and its highest was ₹1714.85 in the past 12 months.
What is Epigral Ltd’s market cap?
Epigral Ltd’s market cap is ₹38.98B.
When is Epigral Ltd’s upcoming earnings report date?
Epigral Ltd’s upcoming earnings report date is Nov 02, 2026 which is in 2 days.
How were Epigral Ltd’s earnings last quarter?
Epigral Ltd released its earnings results on Jul 27, 2026. The company reported ₹23.119 earnings per share for the quarter.
Is Epigral Ltd overvalued?
According to Wall Street analysts Epigral Ltd’s price is currently Overvalued.
Does Epigral Ltd pay dividends?
Epigral Ltd pays a Annually dividend of ₹5 which represents an annual dividend yield of 0.55%. See more information on Epigral Ltd dividends here
What is Epigral Ltd’s EPS estimate?
Epigral Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epigral Ltd have?
Epigral Ltd has 43,141,340 shares outstanding.
What happened to Epigral Ltd’s price movement after its last earnings report?
Epigral Ltd reported an EPS of ₹23.119 in its last earnings report. Following the earnings report the stock price went down -0.284%.
Which hedge fund is a major shareholder of Epigral Ltd?
Currently, no hedge funds are holding shares in IN:EPIGRAL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Epigral Ltd
Epigral Limited operates in the chemical sector, focusing on the production and global distribution of chlor-alkali products and their associated derivatives. Its diverse product range encompasses chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash. Additionally, the company is involved in the trading of agrochemical products. Epigral caters to an extensive list of industries, including CPVC pipes and fittings, wind energy, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soaps and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. Incorporated in 2007 and based in Ahmedabad, India, the company was formerly known as Meghmani Finechem Limited until it adopted the name Epigral Limited in August 2023.
Technical Analysis
Deepak Nitrite Limited
―
Gujarat Alkalies & Chemicals Ltd.
―
Indo Amines Limited
―
Styrenix Performance Materials Ltd
―
Valiant Organics Limited
―